MYC and cancer: With the recent advancements in RNA-based therapies—such as RNA interference, small molecules, and antisense oligonucleotides—which have demonstrated the potential to modulate ncRNA activity [10,11], a better understanding of the role of ncRNAs in the context of MYC metabolism would be of great benefit, opening avenues for discovering synthetic lethality targets of MYC-related functions in cancer.